Welcome to our dedicated page for Vystar news (Ticker: VYST), a resource for investors and traders seeking the latest updates and insights on Vystar stock.
Vystar Corporation (OTCQB: VYST) generates news across several distinct business lines, including Vytex natural rubber latex materials, RxAir UV-C air purification systems, Fluid Energy Conversion technologies, and tokenization of collectibles and digital assets through GoPaid.com and related initiatives. News coverage often reflects product developments, legal milestones, and strategic partnerships described by the company.
Recent announcements have included a binding Letter of Intent to acquire a minority equity stake in GoPaid.com LLC and participate in its proprietary cryptocurrency, along with plans to collaborate with Capital R3alm on R3alm Collectibles and R3alm Oracle platforms focused on tokenized memorabilia and decentralized oracle services. Vystar has also issued updates on Vytex-based mattresses and toppers, enhancements to RxAir air purifiers such as extended-life UV-C bulb cartridges, and progress on integrating Fluid Energy Conversion’s Hughes Reactor technology into next-generation air purification prototypes.
Investors and observers following VYST news can expect disclosures on product launches and relaunches, technology refinements in air purification and fluid energy, developments in Vytex applications, and corporate or legal updates such as court decisions involving convertible note litigation. Because Vystar operates at the intersection of materials science, health-related air quality products, energy-focused fluidics, and Web3 collectibles tokenization, its news flow spans multiple sectors and themes.
This page aggregates Vystar-related press releases and third-party coverage in one place, making it easier to review the company’s reported activities and announcements over time.
Vystar Corporation (OTCQB: VYST) has partnered with Nothing in the Air (NITA) to market its RxAir ultraviolet light air purifier line. NITA aims to enhance VYST's distribution through online and television marketing. The RxAir product is FDA-cleared and proven effective in eliminating airborne pathogens without chemicals. A ROKU advertising campaign launches on June 3, targeting Los Angeles and expanding to other platforms. The campaign emphasizes the importance of indoor air quality and the health benefits of the RxAir air purification system.
Summary not available.
Vystar Corporation (OTCQB: VYST) reported record financial results for Q1 2021, with revenue of $12.87 million, up 117% year-over-year. The surge was attributed to a successful ‘Closing to Remodel’ sale at Rotmans Furniture and increased sales of RxAir UV air purifiers that eliminate over 99.6% of airborne pathogens. Gross profit rose to $6.79 million, a 126% increase. Net income reached $918,127, compared to a loss of $1.37 million in Q1 2020. Operating expenses increased by 51% to $5.82 million, primarily due to heightened advertising and third-party agent fees.
Vystar Corporation (OTCQB: VYST) has appointed Byron Novosad, DDS, to its Board of Directors, replacing retired member Keith Osborn, MD. CEO Steve Rotman expressed gratitude for Dr. Osborn's service and welcomed Dr. Novosad, noting his extensive experience and commitment as an investor and advisor. Dr. Novosad aims to enhance shareholder value through strategic execution and communication of Vystar's vision, particularly in health-related product lines such as RxAir UV purifiers and Vytex deproteinized latex. His background and insights are expected to positively influence Vystar's future growth.
Vystar Corporation (OTCQB: VYST) has partnered with 5W Public Relations to enhance media presence and brand recognition for its RxAir UV light air purification products. This collaboration aims to address growing consumer concerns about airborne disease transmission due to the COVID-19 pandemic. 5WPR will implement a targeted media relations program and influencer campaigns to promote RxAir's effectiveness in eliminating 99.9% of airborne viruses, including various strains of coronaviruses. RxAir products are FDA cleared as Class II Medical Devices, designed initially for healthcare environments.
Vystar Corporation (OTCQB: VYST) has partnered with Corrie MacColl Limited for global market development and distribution of Vytex deproteinized latex. The three-year agreement allows Corrie MacColl to utilize its extensive supply chain and sustainability practices to produce Vytex from its eco-friendly Cameroon plantations. This partnership aims to enhance Vytex's global reach, expected to add shareholder value without significant costs, and positions Vystar to enter new markets in sustainable applications for products like tires and medical devices.
Vystar Corporation (OTCQB: VYST) reports significant advancements amid COVID-19 challenges, enhancing its supply chain and product offerings, particularly through its RxAir UV air purifiers, which have seen increased demand. The company produced over 10,000 units of the RxAir 400 and aims to manufacture the Rx3000 by Q1 2021. Additionally, Rotmans Furniture expects a surge in sales due to a clearance sale and renovation plans. The company is pursuing strategic partnerships to support growth while minimizing debt. Vystar remains committed to spinning off RxAir as a public entity, enhancing shareholder value.
Vystar Corporation (OTCQB: VYST) announces the assembly and testing of its Rx3000® UV-C Light/HEPA Air Purifier prototypes, a Class II medical device designed to inactivate 99.9% of airborne pathogens. The units are being developed to meet rising demand in various sectors due to COVID-19. Strategic Link is facilitating the manufacturing process amidst supply chain challenges. Pre-orders for the Rx3000 will begin on October 18, 2020, highlighting Vystar's commitment to enhancing air quality in healthcare settings and beyond.
Vystar Corporation (OTCQB: VYST) announces that Eagle Hill School is the first school to implement the RxAir 400 UV-C Light Air Purifier Systems across its campus. These FDA-certified devices effectively inactivate 99.9% of airborne viruses and bacteria, enhancing safety for in-person education. The school installed 95 units, ensuring up to six air changes per hour in large spaces. Vystar is offering discounted bulk orders to educational institutions, aiming to promote healthier learning environments. The partnership will showcase the effectiveness of RxAir in reducing airborne pathogen risks.
Vystar Corporation (OTCQB: VYST) has successfully paid off over $2 million in debt since July 1, 2020, including multiple notes and lines of credit. This consolidation is timely as Vystar enters the crucial fourth quarter, with its RxAir UV-C Light air purifier line and Rotmans home furnishings. Notably, the company benefited from $1.4 million in government PPP funding during the COVID-19 shutdown, facilitating debt repayment and operational growth. Vystar's CEO emphasized the solid business position and upcoming production restarts for RxAir units, alongside new product developments.